DTL and head and neck squamous cell carcinoma: found that DTL (CDT2) expression is augmented in head and neck squamous cell carcinoma (HNSCC) and knockdown of DTL by siRNA attenuated the growth of human papillomavirus negative (HPV-ve) HNSCC cells.